01 · Selection
Editorial scope guides coverage, not conclusions.
The United States-oriented public beta contains 41 selected profiles spanning marketed medicines, investigational candidates, unapproved substances, identity records, and safety-review records. It does not cover every peptide or continuously monitor every source. A topic is included when there is enough attributable material for a useful source-linked profile. Inclusion is neither an endorsement nor a ranking of scientific importance. See the exact sources and coverage gaps.
02 · Evidence
Every factual profile note needs a citation.
PeptideScanner uses public records from official trial registries, regulators, and government label repositories. Each profile and update names its supporting source. If a factual statement cannot be tied to a listed source, it is not published. Each profile also shows when its sources were last checked; that date does not mean the source is monitored continuously.
03 · Language
A source only supports what it actually says.
A trial registry can confirm what its record says, not whether a treatment works. A regulator can confirm the action it took. A company or institution can confirm what it said, but that does not independently establish the claim.
04 · Automation
Human review remains responsible for publication.
The current beta requires human review before a profile, update, or correction appears. Software checks names, dates, citation links, and public-data boundaries. AI tools can assist with research, extraction, and editing, but they cannot decide what is true or publish on their own. Read the full automation disclosure.
05 · Corrections
Material changes remain visible.
A material factual correction receives a dated notice identifying what changed, why, and which source supports the change. Routine wording or source updates are labeled separately from factual corrections and retractions. We do not silently overwrite a public factual record. See the public change history.
06 · Publisher
PeptideScanner is accountable for what appears here.
PeptideScanner is published and reviewed by GoodSir Labs, which is responsible for topic selection, the wording published under the PeptideScanner name, and visible corrections. Sources do not approve the site's summaries, and vendors cannot pay for inclusion, ranking, or favorable language. The public methodology, source register, automation disclosure, citations, and version history let readers inspect how the work was produced. The changes and corrections page discloses the current reporting-channel status.